Taizhen Liang - Concepedia

Author

Taizhen Liang

Southern Medical University

Also Known As

Tai-zhen Liang, Taizhen Liang

Publications

258

Citations

H-Index

Concepts

All Affiliations

Southern Medical University Sun Yat-sen University Zhejiang Chinese Medical University Guangdong Pharmaceutical University Twelfth Guangzhou City People's Hospital

About

Taizhen Liang is an author at Southern Medical University specializing in hiv, medicine, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	134
2	Cell Biology	3	3	70
3	Natural Sciences	2	2	52
4	Biochemistry	2	2	52
5	Biomolecular Engineering	1	1	22

Taizhen Liang

Publications

162

Citations

H-Index

Page 1

	Year	Citations
Trilobatin as an <scp>HIV</scp>‐1 entry inhibitor targeting the <scp>HIV</scp>‐1 Gp41 envelope Shuwen Yin, Xuanxuan Zhang, Fangyuan Lai, FEBS Letters Hiv EntryBiochemistryMedicineNatural SciencesImmunology	2018	30
A novel bromodomain inhibitor, CPI-203, serves as an HIV-1 latency-reversing agent by activating positive transcription elongation factor b Taizhen Liang, Xuanxuan Zhang, Fangyuan Lai, Biochemical Pharmacology Hiv-1 Latency-reversing AgentHuman RetrovirusNovel Bromodomain InhibitorImmunologyAntiviral Drug Development	2019	28
The BET bromodomain inhibitor apabetalone induces apoptosis of latent HIV-1 reservoir cells following viral reactivation Xuanxuan Zhang, Jian Lin, Taizhen Liang, Acta Pharmacologica Sinica Viral ReactivationMedicineHuman RetrovirusImmunologyAntiviral Therapy	2018	25
N-Substituted Pyrrole Derivative 12m Inhibits HIV-1 Entry by Targeting Gp41 of HIV-1 Envelope Glycoprotein Jiayin Qiu, Taizhen Liang, Junyan Wu, Frontiers in Pharmacology GlycobiologyPharmacotherapyAntiviral DrugChemical BiologyPharmaceutical Chemistry	2019	22
UHRF1 Suppresses HIV-1 Transcription and Promotes HIV-1 Latency by Competing with p-TEFb for Ubiquitination-Proteasomal Degradation of Tat Taizhen Liang, Qiao Zhang, Ziyao Wu, mBio	2021	18
PR-957, a selective immunoproteasome inhibitor, reactivates latent HIV-1 through p-TEFb activation mediated by HSF-1 Jian Lin, Xuanxuan Zhang, Wanzhen Lu, Biochemical Pharmacology P-tefb ActivationHuman RetrovirusImmunologyAntiviral ResponseSelective Immunoproteasome Inhibitor	2018	17
A synthetic resveratrol analog termed Q205 reactivates latent HIV-1 through activation of P-TEFb Taizhen Liang, Ziyao Wu, Yibin Li, Biochemical Pharmacology MedicineDrug DiscoveryHuman RetrovirusImmunologyAntiviral Response	2021	12
A New Small-Molecule Compound, Q308, Silences Latent HIV-1 Provirus by Suppressing Tat- and FACT-Mediated Transcription Chenliang Zhou, Yifan Huang, Yibin Li, Antimicrobial Agents and Chemotherapy	2021	10

Page 1